Learning Objectives
1. To define imaging strategies in newly diagnosed, recurrent, and advanced disease.
2. To become able to use MET-RADS-P guidelines for whole-body MRI acquisition, reading, and response assessment.
3. To illustrate recent therapeutic advances: i.e. oligometastatic disease and precision medicine approaches.